News

Mylan Laboratories has signed an agreement with Gilead Sciences to increase access to Tenofovir Alafenamide (TAF) based HIV treatments in developing countries. Mylan received non-exclusive rights to manufacture and distribute TAF as both a single agent...

The trial will examine oral beta secretase cleaving enzyme (BACE) inhibitor AZD3293, also known as LY3314814, which reduced levels of amyloid-beta in the cerebro-spinal fluid of Alzheimer's patients and healthy volunteers in phase I studies. Other...

Researchers at Washington University School of Medicine in St. Louis, US, have reported preliminary data from a small clinical trial of a new breast cancer vaccine. Led by Washington University breast cancer surgeon and senior author...

The pan-European medicines verification system uses an anti-tampering device together with 2D barcoding to verify the authenticity of medicinal products and is currently being implemented with all supply chain stakeholders in Europe. It is being introduced...

Researchers at Washington University School of Medicine in St. Louis, US, have reported preliminary data from a small clinical trial of a new breast cancer vaccine.   Led by Washington University breast cancer surgeon and senior...

Japan-based Otsuka Pharmaceutical has signed an agreement to acquire US-based Avanir Pharmaceuticals for $3.5bn. Otsuka, through its wholly-owned subsidiary Otsuka America, will acquire Avanir for $17 per share in cash. Otsuka will launch a...

Japan-based Daiichi Sankyo has signed an agreement with UCB Biopharma to jointly commercialise Lacosamide for the treatment of patients with epilepsy in Japan.   As part of the deal, UCB will manufacture and supply the product...